Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1612.00
-61.55 (-3.68%)
< Home < Back

Sun Pharmaceutical Industries to increase field force in domestic market by 10% in FY23

Date: 06-06-2022

Sun Pharmaceutical Industries is planning to increase its field force in the domestic market by 10 per cent in the current fiscal in order to drive twin objectives of brand focus and geographical expansion. The field force expansion done in FY21 has met with good success and considering the current market conditions.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.